Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder.
about
GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophreniaA critical appraisal of paliperidone long-acting injection in the treatment of schizoaffective disorderThe role of α5 GABAA receptor agonists in the treatment of cognitive deficits in schizophreniaLaminar and cellular analyses of reduced somatostatin gene expression in the subgenual anterior cingulate cortex in major depressionFgfr1 inactivation in the mouse telencephalon results in impaired maturation of interneurons expressing parvalbuminInterneuron Progenitor Transplantation to Treat CNS DysfunctionThe impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophreniaSearching human brain for mechanisms of psychiatric disorders. Implications for studies on schizophrenia.Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotectionPyramidal cell selective ablation of N-methyl-D-aspartate receptor 1 causes increase in cellular and network excitability.Behavioral effects of the benzodiazepine-positive allosteric modulator SH-053-2'F-S-CH₃ in an immune-mediated neurodevelopmental disruption model.Intracortical excitatory and thalamocortical boutons are intact in primary auditory cortex in schizophrenia.Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapiesLamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophreniaPutative psychosis genes in the prefrontal cortex: combined analysis of gene expression microarrays.Transcriptomic evidence for immaturity of the prefrontal cortex in patients with schizophrenia.Biological substrates underpinning diagnosis of major depression.Cortical inhibitory neuron disturbances in schizophrenia: role of the ontogenetic transcription factor Lhx6Early developmental disturbances of cortical inhibitory neurons: contribution to cognitive deficits in schizophrenia.Antipsychotic-induced gene regulation in multiple brain regions.Corresponding decrease in neuronal markers signals progressive parvalbumin neuron loss in MAM schizophrenia modelGene expression analysis implicates a death receptor pathway in schizophrenia pathologyMolecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia.Bipolar disorder type 1 and schizophrenia are accompanied by decreased density of parvalbumin- and somatostatin-positive interneurons in the parahippocampal region.Selective expression of KCNS3 potassium channel α-subunit in parvalbumin-containing GABA neurons in the human prefrontal cortex.Increased interstitial white matter neuron density in the dorsolateral prefrontal cortex of people with schizophrenia.Cortical parvalbumin and somatostatin GABA neurons express distinct endogenous modulators of nicotinic acetylcholine receptors.An upregulation of DNA-methyltransferase 1 and 3a expressed in telencephalic GABAergic neurons of schizophrenia patients is also detected in peripheral blood lymphocytes.Reduced somatostatin in subgenual anterior cingulate cortex in major depression.Lower glutamic acid decarboxylase 65-kDa isoform messenger RNA and protein levels in the prefrontal cortex in schizoaffective disorder but not schizophreniaAssociation study of OPRM1 polymorphisms with Schizophrenia in Han Chinese population.Neurodevelopment, GABA system dysfunction, and schizophreniaAltered cortical expression of GABA-related genes in schizophrenia: illness progression vs developmental disturbanceChanges in cortical interneuron migration contribute to the evolution of the neocortex.Lamina- and cell-specific alterations in cortical somatostatin receptor 2 mRNA expression in schizophreniaSelective pyramidal cell reduction of GABA(A) receptor α1 subunit messenger RNA expression in schizophrenia.Reduced expression of G protein-coupled receptor kinases in schizophrenia but not in schizoaffective disorderChemokine receptors and cortical interneuron dysfunction in schizophrenia.Extracellular matrix abnormalities in schizophreniaMolecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression
P2860
Q24642711-C5044CCF-9B29-458E-BB4E-56839AC83F57Q26766541-B4AFF9C9-8D19-4899-98BE-1605D8DEBD5AQ27026637-AB86D37E-7A8D-4EAB-A728-1E396A59C3EDQ27308130-BB34FF14-4747-4070-9E11-71D5C017FC86Q27316919-826397D1-BA25-4FCA-BFCF-B9FF3086F799Q28077603-CB75DFF3-B165-4A5B-843D-4BCAAC456C94Q28081110-DCE941DA-F9AE-4E80-BB33-3359D992408DQ30375488-FA940259-75AC-4D60-B8B2-BD0E46B745E2Q30386608-BC8CE877-2DD8-4D9F-B3DE-FB2F7BD4475CQ30388341-5CA0E4EB-F454-4144-8ECF-BFA9D7F80C7CQ30405706-0E49E3B6-4BE7-4D7D-8E02-44B68FAD73EFQ30432120-43527B5C-B608-4580-8F02-6400008751EBQ30484459-A9BD9D28-B144-4C94-B934-5D0FBD5DF6DDQ30499642-971C0AE9-9D6F-4A49-83D7-398498CDB30DQ30851360-9E2761C9-0184-4905-AEDC-1A99CE1F9465Q33789078-5D1C4FC3-20D1-4734-954B-6A23C37B0CAFQ33820463-4BFF7D6B-32A9-4927-827D-2F18BA563F34Q34048651-964FC4C1-EAA4-4D91-9733-5152EB997D25Q34048663-136B36BC-3589-46DE-A8EE-E709D1226D0EQ34066954-04735DAE-284F-4B63-8A0F-4695E05EC5BAQ34167594-E6FA9559-AA4A-4BE5-A276-AE55442FB8D2Q34251137-71EE1B59-3480-4CB9-8C50-F8153C821D70Q34306261-0F5284F9-0CCC-48F8-BA53-D46E66FCC25CQ34391520-6F1C95A1-DAE1-47DE-8328-4AE65E95941DQ34399558-A222E380-A701-47B2-B9C2-C77B1E9803E4Q34424435-DAA53E8F-232D-435A-A465-EB85D9031F59Q34491857-635A7B71-87A4-4527-A4D4-733A496E1CEDQ34541215-C7DB21C7-4A22-4ADD-8E23-B1594F1E48DEQ34574517-51018B55-8979-48A5-9CFD-C741AB48866FQ34587796-831218D0-8B62-46E5-B1B9-9E906458F46DQ34656692-C2AADFE3-13E2-404C-B3BE-CB330522C586Q34675943-EE40C630-5A42-42CE-AF81-1D972338BAC6Q34700955-1E8897C7-5EEC-40B3-AAD8-699419B6D259Q34977890-DE863A27-4D9C-4910-9135-3DC51B8771E9Q34987919-2A4F52EC-0A12-47CA-905C-30DCB3D4E1EAQ35171300-C5540B32-EDDC-46A3-ABF8-43D35C82851FQ35196371-A6061758-6AB2-4356-82C4-5ECFC706CFEEQ35593876-16E59336-0EAB-4079-BD0B-9045AA81AFCAQ35603175-01BE6A82-FB0A-4B5F-9202-77A5077B04F0Q35613219-24428440-D59A-437A-A693-9763EA3E01AC
P2860
Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Alterations in somatostatin mR ...... a or schizoaffective disorder.
@ast
Alterations in somatostatin mR ...... a or schizoaffective disorder.
@en
type
label
Alterations in somatostatin mR ...... a or schizoaffective disorder.
@ast
Alterations in somatostatin mR ...... a or schizoaffective disorder.
@en
prefLabel
Alterations in somatostatin mR ...... a or schizoaffective disorder.
@ast
Alterations in somatostatin mR ...... a or schizoaffective disorder.
@en
P2860
P356
P1433
P1476
Alterations in somatostatin mR ...... a or schizoaffective disorder.
@en
P2093
Harvey M Morris
Takanori Hashimoto
P2860
P304
P356
10.1093/CERCOR/BHM186
P577
2008-01-17T00:00:00Z